Enzyme USP15 present a promising new target for ovarian cancer treatment

Дата публикации: 25-09-2026 15:20:14

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30%. Further complicating treatment, standard therapies cause substantial harm to healthy cells alongside cancerous ones. But what if ovarian cancer treatment could more specifically target cancerous cells, causing less harm to the rest of the body?

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026
2	A secret cell alliance may explain why ovarian cancer is so deadly	0	6.21	09-02-2026
3	Malaga oncologists test ground-breaking drug that sheds light on pancreatic cancer	0	18.7	13-07-2026
4	Платинорезистентный рак яичников: новые возможности терапии обсудили на XII конференции RUSSCO «Онкогинекология. Рак шейки матки»	0	6.54	28-03-2026
5	Team finds way to reverse ovarian cancer’s chemo resistance	5	8	25-06-2026
6	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
7	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
8	Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival	0	7.13	04-06-2026
9	Does giving chemotherapy before surgery improve survival and quality of life in women with advanced epithelial ovarian cancer?	0	4.1	01-01-1970

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 8.75. Источник: medicalxpress.com.